Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
NorthStar Medical Technologies Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production for Precision Cancer Therapies.
NorthStar Medical Technologies has announced a multi-year growth capital facility of up to $185 million with Hercules Capital. The financing will include $100 million upfront to accelerate investment in isotope production. The funds will support NorthStar’s growth and expansion initiatives. The capital aims to boost production capabilities for nex-generation precision cancer therapies.
Company Information
Company
NorthStar Medical Technologies
Location
Beloit, Wisconsin, United States
About
NorthStar Medical Technologies, LLC is the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron-accelerator technology. The company focuses on the production of radiopharmaceuticals for next-generation precision cancer therapies. With a commitment to growth and expansion, NorthStar is enhancing its capabilities in isotope production. Their innovative approach aims to significantly impact the field of cancer treatment.
Fundz sees it the moment NorthStar Medical Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BeloitBiotechnologyHealth CareMedicalMedical Device